| | Patients with plasma YKL-40 below the median value | Patients with plasma YKL-40 above the median value | |
| Age, years | 54 ± 9 | 63 ± 11 | 0.01 | Gender, male, n (%) | 21/23 (91%) | 18/23 (78%) | 0.21 | Hypertension, n/total (%) | 10/23 (43%) | 8/23 (35%) | 0.54 | Diabetes mellitus, n/total (%) | 5/23 (22%) | 7/23 (30%) | 0.50 | CVH history, n/total (%) | 8/23 (34%) | 10/23 (43%) | 0.24 | Hyperlipidemia, n/total (%) | 10/23 (43%) | 4/23 (17%) | 0.05 | Body mass index, kg/m2 | 28.9 ± 4.8 | 27.7 ± 3.6 | 0.35 | AF at admission, n/total (%) | 0/23 | 3/23 (13%) | 0.07 | STEMI, n (%) Non-STEMI, n (%) | 11 (48%) 12 (52%) | 13 (56%) 10 (44%) | 0.55 | Application within office time, n Application out of office time, n | 14 (60%) 9 (40%) | 6 (26%) 17 (74%) | 0.01 | NYHA class I, n/total (%) NYHA class II-III, n/total (%) | 21 (91%) 2 (9%) | 12 (52%) 11 (48%) | 0.003 | Systolic blood pressure | 142 ± 32 | 134 ± 21 | 0.38 | Serum glucose, mg/dl | 113 (92–167) | 152 (114–246) | 0.06 | Serum creatinine, mg/dl | 1.05 ± 0.2 | 1.2 ± 0.3 | 0.06 | White blood cell counts | 11.09 ± 3.6 | 10.11 ± 3.7 | 0.39 | Hemogram, mg/dl | 14.5 ± 1.6 | 13 ± 1.7 | 0.09 | Log troponin-I 24 hours | 1.4 ± 0.5 | 1.5 ± 0.8 | 0.71 | Log BNP on admission | 1.6 ± 0.4 | 2.0 ± 0.6 | 0.06 | First-month log BNP | 1.8 ± 0.5 | 2.1 ± 0.4 | 0.04 | First-month log YKL-40 | 1.7 ± 0.2 | 2.0 ± 0.2 | 0.004 | EF (Simpson’s method), % | 58 ± 10 | 57 ± 12 | 0.31 | Tei index | 0.71 ± 0.26 | 0.88 ± 0.28 | 0.03 | LAVi, ml/m2 | 28.9 ± 7.8 | 33.1 ± 11.6 | 0.15 | Mitral lateral e′, cm/s | 9.3 ± 3.3 | 7.7 ± 3.3 | 0.11 | Lateral E/e′, median (IQR) | 9.6 (6.4–12.3) | 9.6 (8.5–18.4) | 0.14 | Mitral septal e′, cm/s | 7.3 ± 2.5 | 5.7 ± 2.0 | 0.02 | Septal E/e′ | 11.9 ± 4.1 | 16.8 ± 7.1 | 0.007 | RV TDI s′, cm/s | 14.6 ± 4.3 | 12.6 ± 3.4 | 0.08 | TAPSE, cm | 2.2 ± 0.4 | 2.3 ± 0.6 | 0.50 | All-cause death | 2/23 (9%) | 12/23 (52%) | 0.001 |
|
|